Commercial modelling and in-depth primary research help us to develop a comprehensive case.
Our insights are based on trusted relationships with KOLs and payers and our experience in analysing clinical and commercial data. The commercial value of an opportunity depends equally on understanding both clinical and market access environment in equal measure and as early as possible during the clinical development process.
The better we understand the business question you need to address, the better we can tailor our work to answer that question. Therefore every groupH assignment starts with a discussion to your business needs before we start presenting any research options. We help our clients in the pharmaceuticals and biotech sectors answer business critical questions such as: